Target intelligence / Profile preview

Inhibitory synaptic factor 1 (INSYN1)

Target
INSYN1
Molecular classification
Scaffold protein, Structural protein of inhibitory synapse, Postsynaptic density component, Protein Largen/Inhibitory synaptic factor 1 family
01

Overview

INSYN1 encodes inhibitory synaptic factor 1, a 292-amino-acid scaffold protein predominantly localized at the postsynaptic density of inhibitory synapses in the brain[1][2][13]. Its primary function is to organize and maintain the molecular machinery needed for effective GABAergic synaptic transmission, acting via interaction with the dystrophin/dystroglycan complex (DGC).[2][4][7][13] Proper INSYN1 localization is critical for synaptic architecture and neural inhibition; loss or mutation leads to defective inhibitory synapse structure, increased neuronal excitability, and cognitive impairments in animal models[2]. Structural analysis reveals an N-terminal coiled-coil region important for protein–protein interactions and synaptic targeting[2][3]. While not a direct therapeutic target or biomarker, INSYN1 plays a key supporting role in inhibitory synaptic physiology and may become relevant in neurodevelopmental and neuropsychiatric diseases related to inhibitory circuit disruption[2][7][13].

Other names
C15orf59InSyn1MGC131524LOC388135Inhibitory synaptic protein 1UPF0583 protein C15orf59
02

Mechanism of action

None known; no direct drugs targeting INSYN1 have been reported

03

Biological functions

Organization of inhibitory postsynaptic potentialSynaptic scaffoldingRegulation of GABAergic inhibitionMaintenance of dystrophin/dystroglycan complex at GABAergic synapsesCoupling inhibitory synaptic machinery to essential neural network activity
04

Disease associations

Potential roles in neurodevelopmental or neuropsychiatric disorders due to disruption of synaptic inhibitionAssociated with Spinocerebellar Ataxia, Autosomal Recessive 10Common Wart (possibly reflecting shared genetic loci but no direct mechanistic link)Cognitive dysfunction related to altered inhibitory synapse architecture

Beyond the preview

Go deeper on Inhibitory synaptic factor 1 (INSYN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitory synaptic factor 1 (INSYN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call